Efficacy of pharmacopuncture for treating children with physical disabilities in uzbekistan

Zohidjon Ismailov N1, Jun-Sang Yu2

  • 1Department of Neurorehabilitation and Oriental Medicine, Tashkent Institute of Postgraduate Medical Education, Tashkent, Uzbekistan ; Republic Children's Rehabilitation Center with diseases of bearing movable system, Tashkent, Uzbekistan.

Insights

Complex rehabilitation with pharmacopuncture effectively treated neuromotor system diseases in children. This approach improved various conditions, including joint disorders and muscle atrophy, demonstrating significant therapeutic benefits.

Area of Science:

  • Pediatrics
  • Neurology
  • Rehabilitation Medicine

Background:

  • Neuromotor system diseases present significant challenges in pediatric care.
  • Conventional treatments and rehabilitation offer some benefits but may not address all aspects of these conditions.

Purpose of the Study:

  • To investigate the efficacy of combining complex rehabilitation with pharmacopuncture treatment.
  • To evaluate the impact of this combined approach on children diagnosed with neuromotor system diseases.

Main Methods:

  • A comparative study involving 70 pediatric patients (ages 5-15) with neuromotor system diseases.
  • A control group (20 patients) received conventional treatments and complex rehabilitation.
  • The treatment group (50 patients) underwent complex rehabilitation combined with pharmacopuncture for 55 days, with 10 days of pharmacopuncture treatment.

Main Results:

  • Significant decreases were observed in conditions such as ankle and knee joint contractures, steppage gait, and shoulder weakness.
  • Improvements were noted in radio-carpal joint disorders, arm and leg hypotrophia, and overall atrophy.
  • Neurological scales indicated positive changes post-treatment in the pharmacopuncture group.

Conclusions:

  • Pharmacopuncture combined with complex rehabilitation demonstrates efficacy in treating pediatric neuromotor system diseases.
  • This integrated therapeutic strategy offers a promising approach for improving functional outcomes and reducing physical impairments.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
851
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505